GLOBAL CARDIOVASCULAR APPLICATION MARKET PR

1. Global Cardiovascular Application Market to Grow with a CAGR of ~6% During 2023-2033; Market to Grow on Account of Growing Pervasiveness of Chronic Cardiovascular Disease Across the Globe Kenneth Research published a report titled “Cardiovascular Application Market: Global Demand Analysis & Opportunity Outlook 2022-2031” which delivers detailed overview of the global cardiovascular application market in terms of market segmentation by type, application, end-user, and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market. The global cardiovascular application market is anticipated to grow with a CAGR of ~6% over the forecast period, i.e., 2023-2033. The market is segmented by device type into diagnostic & monitoring devices, and surgical devices. Amongst these segments diagnostic & monitoring

2. devices segment is projected to garner the largest revenue by the end of 2033. For more information’s@https://www.kennethresearch.com/report- details/global-cardiovascular-application-market/10352452 The global cardiovascular application market is estimated to garner a revenue of ~USD 92 billion by the end of 2033, up from a revenue of ~USD 52 billion in the year 2021. Technology advancement in the field of healthcare, reduction in price for cardiovascular therapeutic devices, and healthcare awareness among people are some of the factors expected to drive the growth of market during the forecast period. Geographically, the global cardiovascular application market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Out of these regions, Asia Pacific is expected to garner the largest revenue by the end of 2033 on the back of increasing geriatric population and growing cases of cardiovascular diseases in the region. The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities,

3. demand for future outlook etc. has also been covered and displayed in the research report. Increasing Risk of Coronary Artery Disease (CAD) to boost the Market Growth Approximately 610,000 people die every year by cause of coronary artery disease (CAD), which is 1 from every four deaths. CAD is one of the most common causes of mortality among adults in US. CAD risk is more in people having high blood pressure, high cholesterol or diabetes. Poor diet and obesity are the main causes for this disease. Also, changing lifestyle and being physically less active increase the risk of CADs. In spite of this, CAD is a preventable disease. It can be screened, identified and treated at a very early stage. Hence the demand for cardiovascular application is expected to boost during the forecast period. However, time consuming approval for novel drugs, biocompatibility issues, and rising heart cost impacting healthcare cost which are expected to operate as key restraint to the growth of global cardiovascular application market over the forecast period. This report also provides the existing competitive scenario of some of the key players of the global cardiovascular application market which includes company profiling of B Braun Melsungen AG, Abbott Laboratories, Johnson & Johnson Private Limited, India Medtronic Private Limited, Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, General Electric Company, Siemens Healthcare GmbH, and Terumo Cardiovascular Systems Corporation. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global

4. cardiovascular application market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. Request Report Sample@ https://www.kennethresearch.com/sample- request-10352452 Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: sales@kennethresearch.com U.S. Phone: +1 313 462 0609